Mesenchymal Stromal Cell‐Based Cell–Drug Conjugates for the Treatment of Acute Liver Failure
Advanced Science · 2026-11 · 13 (63)
DOI: 10.1002/advs.77411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.08.2026. Verfasst von Tenghui Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, People's Republic of …. Hauptthemen laut MEDLINE: Liver Failure, Acute, Rosiglitazone, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Acute liver failure (ALF) is a life‐threatening syndrome characterized by severe inflammatory injury and high mortality. Mesenchymal stromal cells (MSCs) hold therapeutic promise for ALF because of their immunomodulatory and tissue‐repair capacities. However, in the ALF inflammatory microenvironment, characterized by abundant activated M1 macrophages and elevated pro‐inflammatory cytokines, MSCs are susceptible to apoptosis, resulting in low survival and limited therapeutic efficacy. Here, we combined the anti‐inflammatory small‐molecule rosiglitazone with MSCs to construct a cell–drug conjugate (CDC) using MSCs as cellular carriers. Rosiglitazone was encapsulated within nanoparticles coated with neutrophil membranes and anchored onto the MSC surface. Sustained release of rosiglitazone from the MSC surface intrinsically enhanced MSC proliferation and paracrine activity through PI3K–Akt pathway activation and extrinsically modulated the inflammatory microenvironment by promoting macrophage polarization toward an anti‐inflammatory phenotype. In a mouse model of ALF, rosiglitazone nanoparticle‐modified MSCs exhibited enhanced accumulation and prolonged retention in the injured liver, more effectively inhibited hepatocyte apoptosis and promoted hepatocyte proliferation, thereby achieving superior therapeutic efficacy. Thus, our study provides a promising strategy for enhancing MSC‐based therapy in ALF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, People's Republic of China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, People's Republic of China.
- Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou, People's Republic of China.
- Key Laboratory of Biomedical Materials of the Ministry of Education, South China University of Technology, Guangzhou, People's Republic of China.
- Department of General Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
ORCID-Profile: Peng Shi
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- China Postdoctoral Science Foundation
- GJYC Program of Guangzhou
Zitieren
APA
Ye, T., Wu, J., Wu, Z., Liu, X., Luo, J., Yang, L., & Shi, P. (2026). Mesenchymal Stromal Cell‐Based Cell–Drug Conjugates for the Treatment of Acute Liver Failure. Advanced Science, 13(63). https://doi.org/10.1002/advs.77411
Vancouver
Ye T, Wu J, Wu Z, Liu X, Luo J, Yang L, et al. Mesenchymal Stromal Cell‐Based Cell–Drug Conjugates for the Treatment of Acute Liver Failure. Advanced Science. 2026;13(63). doi:10.1002/advs.77411
BibTeX
@article{Ye2026,
author = {Ye, Tenghui and Wu, Jiamin and Wu, Zixin and Liu, Xi and Luo, Jiajia and Yang, Leyi and Shi, Peng},
title = {Mesenchymal Stromal Cell‐Based Cell–Drug Conjugates for the Treatment of Acute Liver Failure},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {63},
doi = {10.1002/advs.77411}
}
EUVIMED